{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:14:50Z","timestamp":1787022890203,"version":"build-2736575974"},"reference-count":57,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"<jats:p>The recent opioid epidemic in the United States has led to rising prevalence of maternal opioid use disorder (OUD). First-line treatment for maternal OUD involves the use of opioid agonist pharmacotherapy, such as methadone or buprenorphine, in addition to cognitive behavioral therapy and counseling. The management of maternal OUD can become overwhelming for both patients and clinicians, especially during the early postpartum period. Therefore, it is imperative that clinicians understand the impact of additional stressors in caring for these patients. Maternal chronic opioid dependence can lead to neonatal opioid withdrawal syndrome after birth. This multisystem condition affects neonatal neurobehavioral functioning and has significant human and socioeconomic consequences. First-line treatment for this syndrome involves intensive nonpharmacologic comforting measures, with maternal presence and involvement being central to ensuring the success of such measures. In this review, we describe the factors that place pregnant and postpartum women with OUD at risk of returning to illicit opioid use. We evaluate these multifaceted personal, social, societal, and systemic factors to inform the development of future clinical care initiatives.<\/jats:p>","DOI":"10.1542\/neo.23-5-e291","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T23:06:00Z","timestamp":1651359960000},"page":"e291-e299","source":"Crossref","is-referenced-by-count":10,"title":["Risk Factors Associated with Perinatal Relapse to Opioid Use Disorder"],"prefix":"10.1542","volume":"23","author":[{"given":"Nanjiba","family":"Nawaz","sequence":"first","affiliation":[{"name":"Penn State College of Medicine, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hester","sequence":"additional","affiliation":[{"name":"Drexel University College of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana N.","family":"Oji-Mmuo","sequence":"additional","affiliation":[{"name":"Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Penn State College of Medicine, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Gomez","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Kentucky, Lexington, KY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia M.","family":"Allen","sequence":"additional","affiliation":[{"name":"Family and Community Medicine, The Arizona University College of Medicine, Tucson, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,5,1]]},"reference":[{"issue":"31","key":"2022050103055374400_B1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999-2014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022050103055374400_B2","unstructured":"Strain\n              E\n            \n          . Opioid use disorder: epidemiology, pharmacology, clinical manifestations, course, screening, assessment, and diagnosis. Available at: https:\/\/www.uptodate.com\/contents\/opioid-use- disorder-epidemiology-pharmacology-clinical-manifestations-course- screening-assessment-and-diagnosis? Accessed February 2, 2022"},{"issue":"2","key":"2022050103055374400_B3","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota","year":"2014","journal-title":"Pediatrics"},{"key":"2022050103055374400_B4","unstructured":"Substance Abuse and Mental Health Services Administration. Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. Available at: https:\/\/www.samhsa.gov\/resource\/ebp\/clinical-guidance-treating-pregnant- parenting-women-opioid-use-disorder-their-infants. Accessed February 2, 2022"},{"issue":"5","key":"2022050103055374400_B5","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"ACOG committee opinion no. 524: opioid abuse, dependence, and addiction in pregnancy","volume":"119","author":"ACOG Committee on Health Care for Underserved Women","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"24","key":"2022050103055374400_B6","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"2022050103055374400_B7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40352-015-0015-5","article-title":"Pregnant women and substance use: fear, stigma, and barriers to care","volume":"3","author":"Stone","year":"2015","journal-title":"Health Justice"},{"issue":"2","key":"2022050103055374400_B8","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"2022050103055374400_B9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/ADM.0b013e31817e6105","article-title":"The opioid dependent mother and newborn dyad: non-pharmacologic care","volume":"2","author":"Velez","year":"2008","journal-title":"J Addict Med"},{"issue":"5","key":"2022050103055374400_B10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1542\/peds.2014-3299","article-title":"Prescription opioid epidemic and infant outcomes","volume":"135","author":"Patrick","year":"2015","journal-title":"Pediatrics"},{"issue":"31","key":"2022050103055374400_B11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.15585\/mmwr.mm6531a2","article-title":"Incidence of neonatal abstinence syndrome\u201428 states, 1999\u20132013","volume":"65","author":"Ko","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2022050103055374400_B12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13722-016-0070-9","article-title":"Prenatal treatment for opioid dependency: observations from a large inner-city clinic","volume":"12","author":"Saia","year":"2017","journal-title":"Addict Sci Clin Pract"},{"issue":"2","key":"2022050103055374400_B13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ogc.2014.02.010","article-title":"Neonatal opioid withdrawal syndrome","volume":"41","author":"Sutter","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"22","key":"2022050103055374400_B14","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1056\/NEJMsa1500439","article-title":"Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs","volume":"372","author":"Tolia","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"2022050103055374400_B15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"J Perinatol"},{"issue":"3","key":"2022050103055374400_B16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/1552-6909.12306","article-title":"Experiences of mothers of infants with neonatal abstinence syndrome in the neonatal intensive care unit","volume":"43","author":"Cleveland","year":"2014","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"1","key":"2022050103055374400_B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/hpeds.2017-0128","article-title":"A novel approach to assessing infants with neonatal abstinence syndrome","volume":"8","author":"Grossman","year":"2018","journal-title":"Hosp Pediatr"},{"issue":"4","key":"2022050103055374400_B18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","article-title":"Association of Rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis","volume":"172","author":"MacMillan","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"7","key":"2022050103055374400_B19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41372-020-0662-9","article-title":"Partnering with parents to improve outcomes for substance exposed newborns-a pilot program","volume":"40","author":"Singh","year":"2020","journal-title":"J Perinatol"},{"issue":"3","key":"2022050103055374400_B20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ajog.2016.10.003","article-title":"Opioid dependence and pregnancy: minimizing stress on the fetal brain","volume":"216","author":"McCarthy","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"2022050103055374400_B21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1542\/hpeds.2018-0238","article-title":"Reduction in length of stay and morphine use for NAS with the \u201cEat, Sleep, Console\u201d method","volume":"9","author":"Blount","year":"2019","journal-title":"Hosp Pediatr"},{"key":"2022050103055374400_B22","doi-asserted-by":"crossref","first-page":"107652","DOI":"10.1016\/j.drugalcdep.2019.107652","article-title":"Treatment for substance use disorders in pregnant women: Motivators and barriers","volume":"205","author":"Frazer","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2022050103055374400_B23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1542\/hpeds.2016-0147","article-title":"Impact of parental presence at infants\u2019 bedside on neonatal abstinence syndrome","volume":"7","author":"Howard","year":"2017","journal-title":"Hosp Pediatr"},{"issue":"1","key":"2022050103055374400_B24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/AOG.0000000000001446","article-title":"Opioid use disorder in pregnancy: health policy and practice in the midst of an epidemic","volume":"128","author":"Krans","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2022050103055374400_B25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clp.2019.02.013","article-title":"Analgesia, opioids, and other drug use during pregnancy and neonatal abstinence syndrome","volume":"46","author":"Jones","year":"2019","journal-title":"Clin Perinatol"},{"key":"2022050103055374400_B26","unstructured":"American College of Obstetricians and Gynecologists (ACOG). Opioid use and opioid use disorder in pregnancy. Available at: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2017\/08\/opioid-use-and-opioid-use-disorder-in-pregnancy. Accessed February 2, 2022"},{"issue":"9","key":"2022050103055374400_B27","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/add.13842","article-title":"The economic burden of neonatal abstinence syndrome in the United States","volume":"112","author":"Corr","year":"2017","journal-title":"Addiction"},{"issue":"1","key":"2022050103055374400_B28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1017\/S0954579407070113","article-title":"Maternal drug abuse versus maternal depression: vulnerability and resilience among school-age and adolescent offspring","volume":"19","author":"Luthar","year":"2007","journal-title":"Dev Psychopathol"},{"issue":"1","key":"2022050103055374400_B29","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.wombi.2018.04.001","article-title":"Reasons for substance use continuation and discontinuation during pregnancy: A qualitative study","volume":"32","author":"Latuskie","year":"2019","journal-title":"Women Birth"},{"issue":"1","key":"2022050103055374400_B30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7517-9-5","article-title":"Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women","volume":"9","author":"Wright","year":"2012","journal-title":"Harm Reduct J"},{"issue":"7","key":"2022050103055374400_B31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archpsyc.65.7.805","article-title":"Psychiatric disorders in pregnant and postpartum women in the United States","volume":"65","author":"Vesga-L\u00f3pez","year":"2008","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"2022050103055374400_B32","first-page":"1257","article-title":"Physical abuse in pregnancy","volume":"149","author":"Stewart","year":"1993","journal-title":"CMAJ"},{"issue":"5","key":"2022050103055374400_B33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2105\/AJPH.80.5.575","article-title":"Violence during pregnancy and substance use","volume":"80","author":"Amaro","year":"1990","journal-title":"Am J Public Health"},{"issue":"4","key":"2022050103055374400_B34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/154099903765448880","article-title":"Depressive symptoms among pregnant women screened in obstetrics settings","volume":"12","author":"Marcus","year":"2003","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"2022050103055374400_B35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ogc.2014.02.004","article-title":"Prenatal and postpartum care of women with substance use disorders","volume":"41","author":"Gopman","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"2-3","key":"2022050103055374400_B36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1891\/rtnp.18.2.149.61285","article-title":"A longitudinal study of maternal postpartum depression symptoms","volume":"18","author":"Horowitz","year":"2004","journal-title":"Res Theory Nurs Pract"},{"issue":"3","key":"2022050103055374400_B37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2105\/AJPH.2015.302973","article-title":"The implications of unintended pregnancies for mental health in later life","volume":"106","author":"Herd","year":"2016","journal-title":"Am J Public Health"},{"issue":"1","key":"2022050103055374400_B38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.infbeh.2009.10.004","article-title":"Comorbid depression and anxiety effects on pregnancy and neonatal outcome","volume":"33","author":"Field","year":"2010","journal-title":"Infant Behav Dev"},{"issue":"1","key":"2022050103055374400_B39","first-page":"e15","article-title":"Depression during pregnancy: rates, risks and consequences--Motherisk Update 2008","volume":"16","author":"Marcus","year":"2009","journal-title":"Can J Clin Pharmacol"},{"issue":"2","key":"2022050103055374400_B40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/YCO.0b013e3283503680","article-title":"Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice","volume":"25","author":"Dunkel Schetter","year":"2012","journal-title":"Curr Opin Psychiatry"},{"issue":"1-2","key":"2022050103055374400_B41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-3782(02)00075-0","article-title":"Prenatal maternal stress: effects on pregnancy and the (unborn) child","volume":"70","author":"Mulder","year":"2002","journal-title":"Early Hum Dev"},{"issue":"4","key":"2022050103055374400_B42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/jwh.2008.0953","article-title":"The prevalence of postpartum depression among women with substance use, an abuse history, or chronic illness: a systematic review","volume":"18","author":"Ross","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"2022050103055374400_B43","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jped.2016.11.005","article-title":"Maternal depression and anxiety and fetal-neonatal growth","volume":"93","author":"Pinto","year":"2017","journal-title":"J Pediatr (Rio J)"},{"key":"2022050103055374400_B44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuroscience.2015.09.001","article-title":"Untreated depression during pregnancy: short- and long-term effects in offspring\u2014a systematic review","volume":"342","author":"Gentile","year":"2017","journal-title":"Neuroscience"},{"issue":"4","key":"2022050103055374400_B45","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ejpain.2011.08.008","article-title":"Peripartum pain management in opioid dependent women","volume":"16","author":"H\u00f6flich","year":"2012","journal-title":"Eur J Pain"},{"issue":"2","key":"2022050103055374400_B46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"issue":"5","key":"2022050103055374400_B47","doi-asserted-by":"crossref","first-page":"488.e1","DOI":"10.1016\/j.ajog.2019.12.001","article-title":"Non-opioid versus opioid analgesia after hospital discharge following cesarean delivery: a randomized equivalence trial","volume":"222","author":"Dinis","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2022050103055374400_B48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1017\/S1092852900008981","article-title":"Pregnancy as a stressful life event","volume":"9","author":"Geller","year":"2004","journal-title":"CNS Spectr"},{"issue":"1","key":"2022050103055374400_B49","doi-asserted-by":"crossref","first-page":"61.e1","DOI":"10.1016\/j.ajog.2009.07.041","article-title":"Psychosocial stress during pregnancy","volume":"202","author":"Woods","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"2022050103055374400_B50","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1503\/cmaj.060235","article-title":"Poverty and health","volume":"174","author":"Murray","year":"2006","journal-title":"CMAJ"},{"issue":"4","key":"2022050103055374400_B51","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/jn\/138.4.799","article-title":"Maternal symptoms of stress, depression, and anxiety are related to nonresponsive feeding styles in a statewide sample of WIC participants","volume":"138","author":"Hurley","year":"2008","journal-title":"J Nutr"},{"key":"2022050103055374400_B52","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.childyouth.2017.06.040","article-title":"Family poverty and neighborhood poverty: links with children\u2019s school readiness before and after the Great Recession","volume":"79","author":"Wolf","year":"2017","journal-title":"Child Youth Serv Rev"},{"key":"2022050103055374400_B53","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ssresearch.2016.08.008","article-title":"Single mother families and employment, race, and poverty in changing economic times","volume":"62","author":"Damaske","year":"2017","journal-title":"Soc Sci Res"},{"key":"2022050103055374400_B54","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.2105\/AJPH.2013.301302","article-title":"Substance-use disorders and poverty as prospective predictors of first-time homelessness in the United States","volume":"103","author":"Thompson","year":"2013","journal-title":"Am J Pub Health"},{"issue":"8","key":"2022050103055374400_B55","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/03630242.2010.532754","article-title":"Health and health care disparities among homeless women","volume":"50","author":"Teruya","year":"2010","journal-title":"Women Health"},{"key":"2022050103055374400_B56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2393-11-13","article-title":"The effectiveness of antenatal care programmes to reduce infant mortality and preterm birth in socially disadvantaged and vulnerable women in high-income countries: a systematic review","volume":"11","author":"Hollowell","year":"2011","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"2022050103055374400_B57","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.wombi.2016.01.001","article-title":"The attitudes of healthcare professionals towards women using illicit substances in pregnancy: a cross-sectional study","volume":"29","author":"Fonti","year":"2016","journal-title":"Women Birth"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/23\/5\/e291\/1281753\/neoreviews.092021cmerev00150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/23\/5\/e291\/1281753\/neoreviews.092021cmerev00150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T23:06:33Z","timestamp":1651359993000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/23\/5\/e291\/186927\/Risk-Factors-Associated-with-Perinatal-Relapse-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,1]]},"published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.23-5-e291","relation":{},"ISSN":["1526-9906"],"issn-type":[{"value":"1526-9906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,1]]}}}